• contact us
  • home
  • rho
  • rho canada ventures
  • twitter   follow us
search
rho Logo
    • About Us
    • Overview
    • Partners
    • Chief Financial Officer
    • Portfolio Overview
Portfolio > Healthcare > Select Historical > Vicuron

Vicuron

Sector:
Healthcare

Location:
New York, NY

Year Funded:
1997

Status:
IPO/Acquired by Pfizer


Summary:
Vicuron discovered, developed and marketed antimicrobial drugs for the treatment of bacterial and fungal infections. 

 

Key Successes
Investments
Case Studies
Energy Technology
Healthcare
Current
Select Historical
3DP
Anacor
AqueSys
Archemix
Dendreon
Dyax
Genetic Therapy
Gloucester Pharmaceuticals
GynoPharma
Health Allies
Human Genome Sciences
LeukoSite
MedImmune
Memory Pharmaceuticals
MPV
NephroGenex
NitroMed
Orametrix
Osteotech
Pharmavene
PHT
Principia
SARcode Bioscience, Inc.
Senomyx
STC
Tercica
TolerRx
Upstate
Vanda
Verathon
Vicuron
Virus Research
IT & Communications
New Media
  • Copyright © 2021 Rho Ventures. All rights reserved.